{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:09:48Z","timestamp":1791252588438,"version":"4.1.0"},"reference-count":70,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Behav. Neurosci."],"DOI":"10.3389\/fnbeh.2014.00290","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T15:13:33Z","timestamp":1409152413000},"source":"Crossref","is-referenced-by-count":139,"title":["A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions"],"prefix":"10.3389","volume":"8","author":[{"given":"Alessandra","family":"Bonito-Oliva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00c3\u00a9bora","family":"Masini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"Fisone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,8,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/archneur.61.12.1906","article-title":"The rate of cognitive decline in Parkinson disease","volume":"61","author":"Aarsland","year":"2004","journal-title":"Arch. Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1743-0003-2-20","article-title":"Gait dynamics in mouse models of Parkinson's disease and Huntington's disease","volume":"2","author":"Amende","year":"2005","journal-title":"J. Neuroeng. Rehabil"},{"key":"B3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(10)70106-X","article-title":"Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Barone","year":"2010","journal-title":"Lancet Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.biopsych.2013.02.015","article-title":"Cognitive impairment and dentate gyrus synaptic dysfunction in experimental parkinsonism","volume":"75","author":"Bonito-Oliva","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1017\/S1461145711000812","article-title":"Dopamine in the hippocampus is cleared by the norepinephrine transporter","volume":"15","author":"Borgkvist","year":"2012","journal-title":"Int. J. Neuropsychopharmacol"},{"key":"B6","first-page":"1","article-title":"Neuroanatomy and pathology of sporadic Parkinson's disease","volume":"201","author":"Braak","year":"2009","journal-title":"Adv. Anat. Embryol. Cell Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"B8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bbr.2009.11.020","article-title":"Striatal 6-OHDA lesion in mice: investigating early neurochemical changes underlying Parkinson's disease","volume":"208","author":"Branchi","year":"2010","journal-title":"Behav. Brain Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/jnr.21642","article-title":"Nonmotor symptoms in parkinson's disease: investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model","volume":"86","author":"Branchi","year":"2008","journal-title":"J. Neurosci. Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1054-3589(08)57010-4","article-title":"Preclinical behavioral models for predicting antipsychotic activity","volume":"57","author":"Castagne","year":"2009","journal-title":"Adv. Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.brainresbull.2011.01.005","article-title":"Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist produces anxiolytic-like effects and reverses abnormal firing activity of projection neurons in the basolateral nucleus of the amygdala in rats with bilateral 6-OHDA lesions","volume":"84","author":"Chen","year":"2011","journal-title":"Brain Res. Bull"},{"key":"B13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0022-510X(99)00198-7","article-title":"The effect of long-term levodopa therapy on depression level in de novo patients with Parkinson's disease","volume":"172","author":"Choi","year":"2000","journal-title":"J. Neurol. Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.npep.2007.02.002","article-title":"Social approach behaviors in oxytocin knockout mice: comparison of two independent lines tested in different laboratory environments","volume":"41","author":"Crawley","year":"2007","journal-title":"Neuropeptides"},{"key":"B15","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1136\/jnnp.34.5.502","article-title":"Psychiatric aspects in Parkinsonism treated with L-dopa","volume":"34","author":"Damasio","year":"1971","journal-title":"J. Neurol. Neurosurg. Psychiatr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/mds.21966","article-title":"Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study","volume":"23","author":"Devos","year":"2008","journal-title":"Mov. Disord"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/jnr.21611","article-title":"6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex","volume":"86","author":"Devoto","year":"2008","journal-title":"J. Neurosci. Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1471-4159.2004.02866.x","article-title":"Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex","volume":"92","author":"Devoto","year":"2005","journal-title":"J. Neurochem"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1212\/WNL.38.8.1237","article-title":"Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration","volume":"38","author":"Doty","year":"1988","journal-title":"Neurology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/mp.2013.3","article-title":"Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease","volume":"19","author":"Drui","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhu076","article-title":"Widespread monoaminergic dysregulation of both motor and non-motor circuits in parkinsonism and Dyskinesia","author":"Engeln","year":"2014","journal-title":"Cereb. Cortex"},{"key":"B22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.neubiorev.2010.06.007","article-title":"Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment","volume":"35","author":"Eskow Jaunarajs","year":"2011","journal-title":"Neurosci. Biobehav. Rev"},{"key":"B23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuroscience.2012.05.052","article-title":"L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson's disease","volume":"218","author":"Eskow Jaunarajs","year":"2012","journal-title":"Neuroscience"},{"key":"B24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/s0165-0270(01)00485-x","article-title":"A simple method to measure stride length as an index of nigrostriatal dysfunction in mice","volume":"113","author":"Fernagut","year":"2002","journal-title":"J. Neurosci. Methods"},{"key":"B25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1460-9568.2008.06346.x","article-title":"Olfactory deficits in mice overexpressing human wildtype alpha-synuclein","volume":"28","author":"Fleming","year":"2008","journal-title":"Eur. J. Neurosci"},{"key":"B26","volume-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"1997"},{"key":"B27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.parkreldis.2008.04.038","article-title":"The neuropathological basis for depression in Parkinson's disease","volume":"15","author":"Frisina","year":"2009","journal-title":"Parkinsonism Relat. Disord"},{"key":"B28","doi-asserted-by":"publisher","first-page":"10520","DOI":"10.1523\/JNEUROSCI.4388-06.2007","article-title":"Vmat2 heterozygous mutant mice display a depressive-like phenotype","volume":"27","author":"Fukui","year":"2007","journal-title":"J. Neurosci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e44736","DOI":"10.1371\/journal.pone.0044736","article-title":"Brain transcriptional and epigenetic associations with autism","volume":"7","author":"Ginsberg","year":"2012","journal-title":"PLoS ONE"},{"key":"B30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ana.410270405","article-title":"Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease","volume":"27","author":"Halliday","year":"1990","journal-title":"Ann. Neurol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/CIA.S11829","article-title":"Role and clinical utility of pramipexole extended release in the treatment of early Parkinson's disease","volume":"7","author":"Hametner","year":"2012","journal-title":"Clin. Interv. Aging"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00222890903272025","article-title":"Treadmill gait analysis characterizes gait alterations in Parkinson's disease and amyotrophic lateral sclerosis mouse models","volume":"42","author":"Hampton","year":"2010","journal-title":"J. Mot. Behav"},{"key":"B33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1242\/jeb.138.1.301","article-title":"Speed, stride frequency and energy-cost per stride - How do they change with body size and gait","volume":"138","author":"Heglund","year":"1988","journal-title":"J. Exp. Biol"},{"key":"B34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1123\/mcj.15.3.359","article-title":"Parkinson's disease influences the structural variations present in the leg swing kinematics","volume":"15","author":"Ivkovic","year":"2011","journal-title":"Motor Control"},{"key":"B35","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jns.2009.07.026","article-title":"Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment","volume":"287","author":"Kim","year":"2009","journal-title":"J. Neurol. Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/brain\/awm239","article-title":"Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease","volume":"131","author":"Kish","year":"2008","journal-title":"Brain"},{"key":"B38","doi-asserted-by":"crossref","first-page":"11411","DOI":"10.1523\/JNEUROSCI.23-36-11411.2003","article-title":"Treadmill locomotion in the intact and spinal mouse","volume":"23","author":"Leblond","year":"2003","journal-title":"J. Neurosci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clinthera.2009.01.012","article-title":"The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies","volume":"31","author":"Leentjens","year":"2009","journal-title":"Clin. Ther"},{"key":"B40","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4088\/JCP.v63n0405","article-title":"Effect of reboxetine on depression in Parkinson's disease patients","volume":"63","author":"Lemke","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacology (Berl.)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.brainres.2004.01.047","article-title":"Olfactory dysfunction occurs in transgenic mice overexpressing human tau protein","volume":"1000","author":"Macknin","year":"2004","journal-title":"Brain Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1136\/jnnp.36.6.925","article-title":"Does levodopa alter depression and psychopathology in Parkinsonism patients?","volume":"36","author":"Marsh","year":"1973","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1212\/01.wnl.0000336340.89821.b3","article-title":"A controlled trial of antidepressants in patients with Parkinson disease and depression","volume":"72","author":"Menza","year":"2009","journal-title":"Neurology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0006-3223(93)90237-8","article-title":"Parkinson's disease and anxiety: comorbidity with depression","volume":"34","author":"Menza","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/archneur.55.1.84","article-title":"Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases","volume":"55","author":"Mesholam","year":"1998","journal-title":"Arch. Neurol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.neures.2004.11.008","article-title":"Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL\/6 mice","volume":"51","author":"Mori","year":"2005","journal-title":"Neurosci. Res"},{"key":"B48","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1523\/JNEUROSCI.22-02-00389.2002","article-title":"Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines","volume":"22","author":"Moron","year":"2002","journal-title":"J. Neurosci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mds.22760","article-title":"Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study","volume":"25","author":"Negre-Pages","year":"2010","journal-title":"Mov. Disord"},{"key":"B50","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/S1471-1931(00)00031-8","article-title":"Levodopa motor complications in Parkinson's disease","volume":"23","author":"Obeso","year":"2000","journal-title":"Trends Neurosci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12640-009-9087-0","article-title":"Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL\/6 mice models early preclinical phase of Parkinson's disease","volume":"17","author":"Prediger","year":"2010","journal-title":"Neurotox. Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jneumeth.2012.12.024","article-title":"Quantitative assessment of locomotion and interlimb coordination in rats after different spinal cord injuries","volume":"213","author":"Redondo-Castro","year":"2013","journal-title":"J. Neurosci. Methods"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"key":"B54","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/ana.21291","article-title":"Association of olfactory dysfunction with risk for future Parkinson's disease","volume":"63","author":"Ross","year":"2008","journal-title":"Ann. Neurol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B56","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.brainres.2010.09.026","article-title":"Sociability and motor functions in Shank1 mutant mice","volume":"1380","author":"Silverman","year":"2011","journal-title":"Brain Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0166-4328(94)90008-6","article-title":"Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions","volume":"61","author":"Simon","year":"1994","journal-title":"Behav. Brain Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.expneurol.2008.01.003","article-title":"Deficits in social behavior and reversal learning are more prevalent in male offspring of VIP deficient female mice","volume":"211","author":"Stack","year":"2008","journal-title":"Exp. Neurol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl.)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.neuroscience.2008.08.035","article-title":"Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease","volume":"156","author":"Tadaiesky","year":"2008","journal-title":"Neuroscience"},{"key":"B61","doi-asserted-by":"publisher","first-page":"8103","DOI":"10.1523\/JNEUROSCI.1495-09.2009","article-title":"Nonmotor symptoms of parkinson's disease revealed in an animal model with reduced monoamine storage capacity","volume":"29","author":"Taylor","year":"2009","journal-title":"J. Neurosci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bbr.2006.04.025","article-title":"Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor","volume":"172","author":"Tillerson","year":"2006","journal-title":"Behav. Brain Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1600-0404.1993.tb04068.x","article-title":"\u00e2\u20ac\u0153Panic attacks\u00e2\u20ac\u009d in Parkinson's disease. A long-term complication of levodopa therapy","volume":"87","author":"Vazquez","year":"1993","journal-title":"Acta Neurol. Scand"},{"key":"B64","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.nbd.2008.07.015","article-title":"Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury","volume":"32","author":"Vuckovic","year":"2008","journal-title":"Neurobiol. Dis"},{"key":"B65","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1212\/WNL.33.7.943","article-title":"Olfactory impairment in Parkinson's disease","volume":"33","author":"Ward","year":"1983","journal-title":"Neurology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/0891988703256053","article-title":"Recognition and treatment of depression in Parkinson's disease","volume":"16","author":"Weintraub","year":"2003","journal-title":"J. Geriatr. Psychiatry Neurol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.bbr.2007.07.002","article-title":"Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats","volume":"184","author":"Winter","year":"2007","journal-title":"Behav. Brain Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/s0018-506x(03)00126-0","article-title":"Effects of sex hormones and gender on attraction thresholds for volatile anal scent gland odors in ferrets","volume":"44","author":"Woodley","year":"2003","journal-title":"Horm. Behav"},{"key":"B69","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1037\/0735-7044.117.1.21","article-title":"Social transmission of food preference in mice: methodology and application to galanin-overexpressing transgenic mice","volume":"117","author":"Wrenn","year":"2003","journal-title":"Behav. Neurosci"},{"key":"B70","doi-asserted-by":"publisher","first-page":"8.24.1","DOI":"10.1002\/0471142301.ns0824s48","article-title":"Simple behavioral assessment of mouse olfaction","volume":"48","author":"Yang","year":"2009","journal-title":"Curr. Protoc. Neurosci"}],"container-title":["Frontiers in Behavioral Neuroscience"],"original-title":[],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T18:22:33Z","timestamp":1650046953000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnbeh.2014.00290\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,27]]},"references-count":70,"URL":"https:\/\/doi.org\/10.3389\/fnbeh.2014.00290","relation":{},"ISSN":["1662-5153"],"issn-type":[{"value":"1662-5153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,27]]}}}